BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 34321461)

  • 1. Exosomal miR-1260b derived from non-small cell lung cancer promotes tumor metastasis through the inhibition of HIPK2.
    Kim DH; Park H; Choi YJ; Kang MH; Kim TK; Pack CG; Choi CM; Lee JC; Rho JK
    Cell Death Dis; 2021 Jul; 12(8):747. PubMed ID: 34321461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-derived exosomal miR-3157-3p promotes angiogenesis, vascular permeability and metastasis by targeting TIMP/KLF2 in non-small cell lung cancer.
    Ma Z; Wei K; Yang F; Guo Z; Pan C; He Y; Wang J; Li Z; Chen L; Chen Y; Xia Y
    Cell Death Dis; 2021 Sep; 12(9):840. PubMed ID: 34497265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-derived exosomal miR-619-5p promotes tumor angiogenesis and metastasis through the inhibition of RCAN1.4.
    Kim DH; Park S; Kim H; Choi YJ; Kim SY; Sung KJ; Sung YH; Choi CM; Yun M; Yi YS; Lee CW; Kim SY; Lee JC; Rho JK
    Cancer Lett; 2020 Apr; 475():2-13. PubMed ID: 32004570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-associated fibroblasts secreted miR-103a-3p suppresses apoptosis and promotes cisplatin resistance in non-small cell lung cancer.
    Wang H; Huang H; Wang L; Liu Y; Wang M; Zhao S; Lu G; Kang X
    Aging (Albany NY); 2021 May; 13(10):14456-14468. PubMed ID: 33999859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosome-mediated transfer of miR-1260b promotes cell invasion through Wnt/β-catenin signaling pathway in lung adenocarcinoma.
    Xia Y; Wei K; Hu LQ; Zhou CR; Lu ZB; Zhan GS; Pan XL; Pan CF; Wang J; Wen W; Xu J; He ZC; Huang CJ; Chen L
    J Cell Physiol; 2020 Oct; 235(10):6843-6853. PubMed ID: 32026462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal EGFR and miR-381-3P Mediate HPV-16 E7 Oncoprotein-Induced Angiogenesis of Non-Small Cell Lung Cancer.
    Zhan R; Yu H; Zhang G; Ding Q; Li H; Li X; Tang X
    Front Biosci (Landmark Ed); 2024 May; 29(5):189. PubMed ID: 38812317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomal Transfer Of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance In NSCLC Through Activating Autophagy.
    Ma Y; Yuwen D; Chen J; Zheng B; Gao J; Fan M; Xue W; Wang Y; Li W; Shu Y; Xu Q; Shen Y
    Int J Nanomedicine; 2019; 14():8121-8132. PubMed ID: 31632022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-1260b promotes the migration and invasion in non-small cell lung cancer via targeting PTPRK.
    Xu L; Xu X; Huang H; Ma Z; Zhang S; Niu P; Chen Y; Ping J; Lu P; Yu C; Min L; Chen J; Dai L; Dong S
    Pathol Res Pract; 2018 May; 214(5):776-783. PubMed ID: 29628123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal miR-338-3p suppresses non-small-cell lung cancer cells metastasis by inhibiting CHL1 through the MAPK signaling pathway.
    Tian W; Yang X; Yang H; Lv M; Sun X; Zhou B
    Cell Death Dis; 2021 Oct; 12(11):1030. PubMed ID: 34718336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomal circ_PIP5K1A regulates the progression of non-small cell lung cancer and cisplatin sensitivity by miR-101/ABCC1 axis.
    Shao N; Song L; Sun X
    Mol Cell Biochem; 2021 Jun; 476(6):2253-2267. PubMed ID: 33570734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomal miR-1229 derived from colorectal cancer cells promotes angiogenesis by targeting HIPK2.
    Hu HY; Yu CH; Zhang HH; Zhang SZ; Yu WY; Yang Y; Chen Q
    Int J Biol Macromol; 2019 Jul; 132():470-477. PubMed ID: 30936013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
    Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
    Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exosomal miR-4443 promotes cisplatin resistance in non-small cell lung carcinoma by regulating FSP1 m6A modification-mediated ferroptosis.
    Song Z; Jia G; Ma P; Cang S
    Life Sci; 2021 Jul; 276():119399. PubMed ID: 33781830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-1260b, mediated by YY1, activates KIT signaling by targeting SOCS6 to regulate cell proliferation and apoptosis in NSCLC.
    Xia Y; Wei K; Yang FM; Hu LQ; Pan CF; Pan XL; Wu WB; Wang J; Wen W; He ZC; Xu J; Xu XF; Zhu Q; Chen L
    Cell Death Dis; 2019 Feb; 10(2):112. PubMed ID: 30737371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-derived exosomal miR-221-3p promotes angiogenesis by targeting THBS2 in cervical squamous cell carcinoma.
    Wu XG; Zhou CF; Zhang YM; Yan RM; Wei WF; Chen XJ; Yi HY; Liang LJ; Fan LS; Liang L; Wu S; Wang W
    Angiogenesis; 2019 Aug; 22(3):397-410. PubMed ID: 30993566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomal miR-106b serves as a novel marker for lung cancer and promotes cancer metastasis via targeting PTEN.
    Sun S; Chen H; Xu C; Zhang Y; Zhang Q; Chen L; Ding Q; Deng Z
    Life Sci; 2020 Mar; 244():117297. PubMed ID: 31954745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-221-3p targets HIPK2 to promote diabetic wound healing.
    Yu Q; Liu L; Zhang X; Chang H; Ma S; Xie Z; Tang S; Ju X; Zhu H; Shen B; Zhang Q
    Microvasc Res; 2022 Mar; 140():104306. PubMed ID: 34973299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.
    Liu J; Lu KH; Liu ZL; Sun M; De W; Wang ZX
    BMC Cancer; 2012 Nov; 12():519. PubMed ID: 23151088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SNHG14 silencing suppresses the progression and promotes cisplatin sensitivity in non-small cell lung cancer.
    Jiao P; Hou J; Yao M; Wu J; Ren G
    Biomed Pharmacother; 2019 Sep; 117():109164. PubMed ID: 31252267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.